Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Stanley Fahn

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Living Beings

Procedures

Concepts & Ideas

Pedigree

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Ravina Bernard; Tanner Caroline; Dieuliis Diane; Eberly Shirley; Flagg Emily; Galpern Wendy R; Fahn Stanley; Goetz Christopher G; Grate Stephen; Kurlan Roger; Lang Anthony E; Marek Kenneth; Kieburtz Karl; Oakes David; Elliott Robin; Shoulson Ira;
A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
Clark Lorraine N; Kartsaklis Lykourgos A; Wolf Gilbert Rebecca; Dorado Beatriz; Ross Barbara M; Kisselev Sergey; Verbitsky Miguel; Mejia-Santana Helen; Cote Lucien J; Andrews Howard; Vonsattel Jean-Paul; Fahn Stanley; Mayeux Richard; Honig Lawrence S; Marder Karen
Association of glucocerebrosidase mutations with dementia with lewy bodies.
Lang Anthony E; Angel Michael; Bhatia Kailash; Chen Robert; Fahn Stanley; Hallett Mark; Schrag Anette; Thompson Philip
Myoclonus in complex regional pain syndrome.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Stanley Fahn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ravina Bernard; Tanner Caroline; Dieuliis Diane; Eberly Shirley; Flagg Emily; Galpern Wendy R; Fahn Stanley; Goetz Christopher G; Grate Stephen; Kurlan Roger; Lang Anthony E; Marek Kenneth; Kieburtz Karl; Oakes David; Elliott Robin; Shoulson Ira;
A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
Movement disorders : official journal of the Movement Disorder Society 2009;24(14):2081-90.
2009: Clark Lorraine N; Kartsaklis Lykourgos A; Wolf Gilbert Rebecca; Dorado Beatriz; Ross Barbara M; Kisselev Sergey; Verbitsky Miguel; Mejia-Santana Helen; Cote Lucien J; Andrews Howard; Vonsattel Jean-Paul; Fahn Stanley; Mayeux Richard; Honig Lawrence S; Marder Karen
Association of glucocerebrosidase mutations with dementia with lewy bodies.
Archives of neurology 2009;66(5):578-83.
2009: Lang Anthony E; Angel Michael; Bhatia Kailash; Chen Robert; Fahn Stanley; Hallett Mark; Schrag Anette; Thompson Philip
Myoclonus in complex regional pain syndrome.
Movement disorders : official journal of the Movement Disorder Society 2009;24(2):314-6; author reply 316.
2008: Fahn Stanley
How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?
Annals of neurology 2008;64 Suppl 2():S56-64.
2008: Goetz Christopher G; Tilley Barbara C; Shaftman Stephanie R; Stebbins Glenn T; Fahn Stanley; Martinez-Martin Pablo; Poewe Werner; Sampaio Cristina; Stern Matthew B; Dodel Richard; Dubois Bruno; Holloway Robert; Jankovic Joseph; Kulisevsky Jaime; Lang Anthony E; Lees Andrew; Leurgans Sue; LeWitt Peter A; Nyenhuis David; Olanow C Warren; Rascol Olivier; Schrag Anette; Teresi Jeanne A; van Hilten Jacobus J; LaPelle Nancy;
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2129-70.
2008: Schifitto G; Friedman J H; Oakes D; Shulman L; Comella C L; Marek K; Fahn S;
Fatigue in levodopa-naive subjects with Parkinson disease.
Neurology 2008;71(7):481-5.
2008: Schwarzschild Michael A; Schwid Steven R; Marek Kenneth; Watts Arthur; Lang Anthony E; Oakes David; Shoulson Ira; Ascherio Alberto; Hyson Christopher; Gorbold Emily; Rudolph Alice; Kieburtz Karl; Fahn Stanley; Gauger Lisa; Goetz Christopher; Seibyl John; Forrest Misser; Ondrasik John
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
Archives of neurology 2008;65(6):716-23.
2008: Frank Samuel; Ondo William; Fahn Stanley; Hunter Christine; Oakes David; Plumb Sandra; Marshall Frederick; Shoulson Ira; Eberly Shirley; Walker Francis; Factor Stewart; Hunt Vicki; Shinaman Aileen; Jankovic Joseph
A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
Clinical neuropharmacology 2008;31(3):127-33.
2008: Wang Yuanjia; Clark Lorraine N; Louis Elan D; Mejia-Santana Helen; Harris Juliette; Cote Lucien J; Waters Cheryl; Andrews Howard; Ford Blair; Frucht Steven; Fahn Stanley; Ottman Ruth; Rabinowitz Daniel; Marder Karen
Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method.
Archives of neurology 2008;65(4):467-74.
2008: Goetz Christopher G; Wuu Joanne; McDermott Michael P; Adler Charles H; Fahn Stanley; Freed Curt R; Hauser Robert A; Olanow Warren C; Shoulson Ira; Tandon P K; Leurgans Sue
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.
Movement disorders : official journal of the Movement Disorder Society 2008;23(5):690-9.
2008: Fahn Stanley
The history of dopamine and levodopa in the treatment of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23 Suppl 3():S497-508.
2007: McClelland S; Vonsattel J P; Garcia R E; Amaya M D; Winfield L M; Pullman S L; Yu Q; Fahn S; Ford B; Goodman R R
Relationship of clinical efficacy to postmortem-determined anatomic subthalamic stimulation in Parkinson syndrome.
Clinical neuropathology 2007;26(6):267-75.
2007: Clark L N; Ross B M; Wang Y; Mejia-Santana H; Harris J; Louis E D; Cote L J; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
Neurology 2007;69(12):1270-7.
2007: Sanotsky Yanush; Lesyk Roman; Fedoryshyn Lyudmyla; Komnatska Iryna; Matviyenko Yuriy; Fahn Stanley
Manganic encephalopathy due to "ephedrone" abuse.
Movement disorders : official journal of the Movement Disorder Society 2007;22(9):1337-43.
2007: Clark Lorraine N; Haamer Eneli; Mejia-Santana Helen; Harris Juliette; Lesage Suzanne; Durr Alexandra; Bs Sabine Janin; Hedrich Katja; Louis Elan D; Cote Lucien J; Andrews Howard; Fahn Stanley; Waters Cheryl; Ford Blair; Frucht Steven; Scott William; Klein Christine; Brice Alexis; Roomere Hanno; Ottman Ruth; Marder Karen
Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene.
Movement disorders : official journal of the Movement Disorder Society 2007;22(7):932-7.
2007: Lippa C F; Duda J E; Grossman M; Hurtig H I; Aarsland D; Boeve B F; Brooks D J; Dickson D W; Dubois B; Emre M; Fahn S; Farmer J M; Galasko D; Galvin J E; Goetz C G; Growdon J H; Gwinn-Hardy K A; Hardy J; Heutink P; Iwatsubo T; Kosaka K; Lee V M-Y; Leverenz J B; Masliah E; McKeith I G; Nussbaum R L; Olanow C W; Ravina B M; Singleton A B; Tanner C M; Trojanowski J Q; Wszolek Z K;
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.
Neurology 2007;68(11):812-9.
2007: Nirenberg Melissa J; Libien Jenny; Vonsattel Jean-Paul; Fahn Stanley
Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):251-4.
2007: Goetz Christopher G; Fahn Stanley; Martinez-Martin Pablo; Poewe Werner; Sampaio Cristina; Stebbins Glenn T; Stern Matthew B; Tilley Barbara C; Dodel Richard; Dubois Bruno; Holloway Robert; Jankovic Joseph; Kulisevsky Jaime; Lang Anthony E; Lees Andrew; Leurgans Sue; LeWitt Peter A; Nyenhuis David; Olanow C Warren; Rascol Olivier; Schrag Anette; Teresi Jeanne A; Van Hilten Jacobus J; LaPelle Nancy
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
Movement disorders : official journal of the Movement Disorder Society 2007;22(1):41-7.
2006: Clark L N; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis E D; Cote L J; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
Neurology 2006;67(10):1786-91.
2006: deMarcaida J Antonelle; Schwid Steven R; White William B; Blindauer Karen; Fahn Stanley; Kieburtz Karl; Stern Matthew; Shoulson Ira;
Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline.
Movement disorders : official journal of the Movement Disorder Society 2006;21(10):1716-21.
2006: Elmer L; Schwid S; Eberly S; Goetz C; Fahn S; Kieburtz K; Oakes D; Blindauer K; Salzman P; Oren S; Prisco U L; Stern M; Shoulson I;
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms.
Journal of the neurological sciences 2006;248(1-2):78-83.
2006: Biglan Kevin M; Schwid Steven; Eberly Shirley; Blindauer Karen; Fahn Stanley; Goren Tamar; Kieburtz Karl; Oakes David; Plumb Sandra; Siderowf Andrew; Stern Matthew; Shoulson Ira;
Rasagiline improves quality of life in patients with early Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2006;21(5):616-23.
2006: Clark Lorraine N; Afridi Shehla; Karlins Eric; Wang Yuanjia; Mejia-Santana Helen; Harris Juliette; Louis Elan D; Cote Lucien J; Andrews Howard; Fahn Stanley; Waters Cheryl; Ford Blair; Frucht Steven; Ottman Ruth; Marder Karen
Case-control study of the parkin gene in early-onset Parkinson disease.
Archives of neurology 2006;63(4):548-52.
2006: Portera-Cailliau Carlos; Victor Daryl; Frucht Steven; Fahn Stanley
Movement disorders fellowship training program at Columbia University Medical Center in 2001-2002.
Movement disorders : official journal of the Movement Disorder Society 2006;21(4):479-85.
2006: Blindauer Karen; Shoulson Ira; Oakes David; Kieburtz Karl; Schwid Steven; Fahn Stanley; Stern Matthew; Goetz Christopher; Nutt John; Goren Sari; Sayag Naim; Scolnik Marisa; Levy Ruth; Eyal Eli; Salzman Phyllis; Pagano Mary;
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations.
Archives of neurology 2006;63(2):210-6.
2006: Fahn S
Levodopa in the treatment of Parkinson's disease.
Journal of neural transmission. Supplementum 2006;(71):1-15.
2006: Fahn S
A new look at levodopa based on the ELLDOPA study.
Journal of neural transmission. Supplementum 2006;(70):419-26.
2005: Fahn Stanley;
Does levodopa slow or hasten the rate of progression of Parkinson's disease?
Journal of neurology 2005;252 Suppl 4():IV37-IV42.
2005: Marras Connie; Lang Anthony E; Oakes David; McDermott Michael P; Kieburtz Karl; Shoulson Ira; Tanner Caroline M; Fahn Stanley
High-dosage vitamin E supplementation and all-cause mortality.
Annals of internal medicine 2005;143(2):152-3; author reply 156-8.
2005: Levy Gilberto; Louis Elan D; Cote Lucien; Perez Mario; Mejia-Santana Helen; Andrews Howard; Harris Juliette; Waters Cheryl; Ford Blair; Frucht Steven; Fahn Stanley; Marder Karen
Contribution of aging to the severity of different motor signs in Parkinson disease.
Archives of neurology 2005;62(3):467-72.
2005: Ravina B; Eidelberg D; Ahlskog J E; Albin R L; Brooks D J; Carbon M; Dhawan V; Feigin A; Fahn S; Guttman M; Gwinn-Hardy K; McFarland H; Innis R; Katz R G; Kieburtz K; Kish S J; Lange N; Langston J W; Marek K; Morin L; Moy C; Murphy D; Oertel W H; Oliver G; Palesch Y; Powers W; Seibyl J; Sethi K D; Shults C W; Sheehy P; Stoessl A J; Holloway R
The role of radiotracer imaging in Parkinson disease.
Neurology 2005;64(2):208-15.
2005: Clark Lorraine N; Nicolai Angelique; Afridi Shehla; Harris Juliette; Mejia-Santana Helen; Strug Lisa; Cote Lucien J; Louis Elan D; Andrews Howard; Waters Cheryl; Ford Blair; Frucht Steven; Fahn Stanley; Mayeux Richard; Ottman Ruth; Marder K
Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity.
Movement disorders : official journal of the Movement Disorder Society 2005;20(1):100-3.
2005: Williams Daniel T; Ford Blair; Fahn Stanley
Treatment issues in psychogenic-neuropsychiatric movement disorders.
Advances in neurology 2005;96():350-63.
2004: Fahn Stanley; Oakes David; Shoulson Ira; Kieburtz Karl; Rudolph Alice; Lang Anthony; Olanow C Warren; Tanner Caroline; Marek Kenneth;
Levodopa and the progression of Parkinson's disease.
The New England journal of medicine 2004;351(24):2498-508.
2004: Margolis Russell L; Holmes Susan E; Rosenblatt Adam; Gourley Lisa; O'Hearn Elizabeth; Ross Christopher A; Seltzer William K; Walker Ruth H; Ashizawa Tetsuo; Rasmussen Astrid; Hayden Michael; Almqvist Elisabeth W; Harris Juliette; Fahn Stanley; MacDonald Marcy E; Mysore Jayalakshmi; Shimohata Takayoshi; Tsuji Shoji; Potter Nicholas; Nakaso Kazuhiro; Adachi Yoshiki; Nakashima Kenji; Bird Thomas; Krause Amanda; Greenstein Penny
Huntington's Disease-like 2 (HDL2) in North America and Japan.
Annals of neurology 2004;56(5):670-4.
2004: Fahn Stanley
ALS lessons learned from other neurological diseases. Parkinson's disease.
Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 2004;5 Suppl 1():26-30.
2004: Ford B; Winfield L; Pullman S L; Frucht S J; Du Y; Greene P; Cheringal J H; Yu Q; Cote L J; Fahn S; McKhann G M; Goodman R R
Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up.
Journal of neurology, neurosurgery, and psychiatry 2004;75(9):1255-9.
2004: Gordon Paul H; Fahn Stanley; Chin Steven; Golbe Lawrence I; Lynch Timothy; Eidelberg David
Woman with a 26-year history of parkinsonism, supranuclear ophthalmoplegia, and loss of postural reflexes.
Movement disorders : official journal of the Movement Disorder Society 2004;19(8):950-61.
2004: Holloway Robert G; Shoulson Ira; Fahn Stanley; Kieburtz Karl; Lang Anthony; Marek Kenneth; McDermott Michael; Seibyl John; Weiner William; Musch Bruno; Kamp Cornelia; Welsh Mickie; Shinaman Aileen; Pahwa Rajesh; Barclay Lynn; Hubble Jean; LeWitt Peter; Miyasaki Janis; Suchowersky Oksana; Stacy Mark; Russell David S; Ford Blair; Hammerstad John; Riley David; Standaert David; Wooten Frederick; Factor Stewart; Jankovic Joseph; Atassi Farah; Kurlan Roger; Panisset Michel; Rajput Ali; Rodnitzky Robert; Shults Cliff; Petsinger Giselle; Waters Cheryl; Pfeiffer Ronald; Biglan Kevin; Borchert Leona; Montgomery Amy; Sutherland Laura; Weeks Carolyn; DeAngelis Maryan; Sime Elspeth; Wood Susan; Pantella Carol; Harrigan Mary; Fussell Barbara; Dillon Sandra; Alexander-Brown Barbara; Rainey Pamela; Tennis Marsha; Rost-Ruffner Elke; Brown Diane; Evans Sharon; Berry Debra; Hall Jean; Shirley Theresa; Dobson Judith; Fontaine Deborah; Pfeiffer Brenda; Brocht Alicia; Bennett Susan; Daigneault Susan; Hodgeman Karen; O'Connell Carolynn; Ross Tori; Richard Karen; Watts Arthur;
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Archives of neurology 2004;61(7):1044-53.
2004: Levy Gilberto; Louis Elan D; Mejia-Santana Helen; Côté Lucien; Andrews Howard; Harris Juliette; Waters Cheryl; Ford Blair; Frucht Steven; Fahn Stanley; Ottman Ruth; Marder Karen
Lack of familial aggregation of Parkinson disease and Alzheimer disease.
Archives of neurology 2004;61(7):1033-9.
2004: Clark Lorraine N; Afridi Shehla; Mejia-Santana Helen; Harris Juliette; Louis Elan D; Cote Lucien J; Andrews Howard; Singleton Andrew; Wavrant De-Vrieze Fabienne; Hardy John; Mayeux Richard; Fahn Stanley; Waters Cheryl; Ford Blair; Frucht Steven; Ottman Ruth; Marder Karen
Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations.
Movement disorders : official journal of the Movement Disorder Society 2004;19(7):796-800.
2004: Gordon Paul H; Yu Qiping; Qualls Clifford; Winfield Hal; Dillon Sandra; Greene Paul E; Fahn Stanley; Breeze Robert E; Freed Curt R; Pullman Seth L
Reaction time and movement time after embryonic cell implantation in Parkinson disease.
Archives of neurology 2004;61(6):858-61.
2004: Agarwal Pinky; Fahn Stanley; Frucht Steven J
Diagnosis and management of pergolide-induced fibrosis.
Movement disorders : official journal of the Movement Disorder Society 2004;19(6):699-704.
2004: Freed Curt R; Breeze Robert E; Fahn Stanley; Eidelberg David
Preoperative response to levodopa is the best predictor of transplant outcome.
Annals of neurology 2004;55(6):896; author reply 896-7.
2004: McRae Cynthia; Cherin Eva; Yamazaki T Gayle; Diem Gretchen; Vo Alexander H; Russell Dan; Ellgring J Heiner; Fahn Stanley; Greene Paul; Dillon Sandra; Winfield Hal; Bjugstad Kimberly B; Freed Curt R
Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial.
Archives of general psychiatry 2004;61(4):412-20.
2004: Fahn Stanley; Sulzer David
Neurodegeneration and neuroprotection in Parkinson disease.
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 2004;1(1):139-54.
2004: Fahn Stanley
Deep-brain stimulation extends relief from Parkinson's. Electrodes deep in the brain continue relieving Parkinson's disease symptoms for five years.
Health news (Waltham, Mass.) 2004;10(1):6-7.
2004: Munhoz R P; Li J-Y; Kurtinecz M; Piboolnurak P; Constantino A; Fahn S; Lang A E
Evaluation of the pull test technique in assessing postural instability in Parkinson's disease.
Neurology 2004;62(1):125-7.
2004: Furukawa Yoshiaki; Kish Stephen J; Fahn Stanley
Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency.
Annals of neurology 2004;55(1):147-8.
2003: Rosenberg Roger N; Pedley Timothy A; Baringer J Richard; Fahn Stanley; Lisak Robert P; Mayeux Richard P; Olson Sandra F; Ringel Steven P; Rowland Lewis P; Selzer Michael E
At jeopardy: the NIH as we know it.
Neurorehabilitation and neural repair 2003;17(4):203-5.
2003: Cohen Oren; Fahn Stanley; Frucht Steven J
Severe cervical dystonia in pathologically proven Parkinson's disease and dementia.
Movement disorders : official journal of the Movement Disorder Society 2003;18(11):1381-2.
2003: Louis E D; Levy G; Mejia-Santana H; Cote L; Andrews H; Harris J; Waters C; Ford B; Frucht S; Fahn S; Ottman R; Marder K
Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD.
Neurology 2003;61(7):931-6.
2003: Marder Karen; Levy Gilberto; Louis Elan D; Mejia-Santana Helen; Cote Lucien; Andrews Howard; Harris Juliette; Waters Cheryl; Ford Blair; Frucht Steven; Fahn Stanley; Ottman Ruth
Familial aggregation of early- and late-onset Parkinson's disease.
Annals of neurology 2003;54(4):507-13.
2003: Rosenberg Roger N; Pedley Timothy A; Baringer J Richard; Fahn Stanley; Lisak Robert P; Mayeux Richard P; Olson Sandra F; Ringel Steven P; Rowland Lewis P; Selzer Michael E
At jeopardy: the NIH as we know it.
Archives of neurology 2003;60(9):1191-2.
2003: Marder K; Levy G; Louis E D; Mejia-Santana H; Cote L; Andrews H; Harris J; Waters C; Ford B; Frucht S; Fahn S; Ottman R
Accuracy of family history data on Parkinson's disease.
Neurology 2003;61(1):18-23.
2003: Fahn Stanley
Description of Parkinson's disease as a clinical syndrome.
Annals of the New York Academy of Sciences 2003;991():1-14.
2003: Trott C T; Fahn S; Greene P; Dillon S; Winfield H; Winfield L; Kao R; Eidelberg D; Freed C R; Breeze R E; Stern Y
Cognition following bilateral implants of embryonic dopamine neurons in PD: a double blind study.
Neurology 2003;60(12):1938-43.
2003: McRae Cynthia; Cherin Eva; Diem Gretchen; Vo Alexander H; Ellgring J Heiner; Russell Dan; Fahn Stanley; Freed Curt
Does personality change as a result of fetal tissue transplantation in the brain?
Journal of neurology 2003;250(3):282-6.
2003: Lyons Kelly E; Pahwa Rajesh; Comella Cynthia L; Eisa Mahmood S; Elble Rodger J; Fahn Stanley; Jankovic Joseph; Juncos Jorge L; Koller William C; Ondo William G; Sethi Kapil D; Stern Matthew B; Tanner Caroline M; Tintner Ron; Watts Ray L
Benefits and risks of pharmacological treatments for essential tremor.
Drug safety : an international journal of medical toxicology and drug experience 2003;26(7):461-81.
2002: Bressman S B; Raymond D; Wendt K; Saunders-Pullman R; De Leon D; Fahn S; Ozelius L; Risch N
Diagnostic criteria for dystonia in DYT1 families.
Neurology 2002;59(11):1780-2.
2002: Gordon P H; Pullman S L; Louis E D; Frucht S J; Fahn S
Mirtazapine in Parkinsonian tremor.
Parkinsonism & related disorders 2002;9(2):125-6.
2002: Greene Paul E; Fahn Stanley
Status of fetal tissue transplantation for the treatment of advanced Parkinson disease.
Neurosurgical focus 2002;13(5):e3.
2002: Ma Yilong; Feigin Andrew; Dhawan Vijay; Fukuda Masafumi; Shi Qiuhu; Greene Paul; Breeze Robert; Fahn Stanley; Freed Curt; Eidelberg David
Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.
Annals of neurology 2002;52(5):628-34.
2002: Kock Norman; Müller Birgitt; Vieregge Peter; Pramstaller Peter P; Marder Karen; Abbruzzese Giovanni; Martinelli Paolo; Lang Anthony E; Jacobs Helfried; Hagenah Johann; Harris Juliette; Meija-Santana Helen; Fahn Stanley; Hedrich Katja; Kann Martin; Gehlken Ulrike; Culjkovic Biljana; Schwinger Eberhard; Wszolek Zbigniew K; Zühlke Christine; Klein Christine
Role of SCA2 mutations in early- and late-onset dopa-responsive parkinsonism.
Annals of neurology 2002;52(2):257-8; author reply 258.
2002: Louis Elan D; Levy Gilberto; Côte Lucien J; Mejia Helen; Fahn Stanley; Marder Karen
Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses.
Movement disorders : official journal of the Movement Disorder Society 2002;17(3):513-7.
2002: Shoulson Ira; Oakes David; Fahn Stanley; Lang Anthony; Langston J William; LeWitt Peter; Olanow C Warren; Penney John B; Tanner Caroline; Kieburtz Karl; Rudolph Alice;
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.
Annals of neurology 2002;51(5):604-12.
2002: Hedrich K; Marder K; Harris J; Kann M; Lynch T; Meija-Santana H; Pramstaller P P; Schwinger E; Bressman S B; Fahn S; Klein C
Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations.
Neurology 2002;58(8):1239-46.
2002: Pedley Timothy A; Swift Thomas R; Miller Aaron; Fahn Stanley
Pharmaceutical industry support of the AAN Annual Meeting: policies and violation.
Neurology 2002;58(4):519-21.
2002: Chuang C; Fahn S; Frucht S J
The natural history and treatment of acquired hemidystonia: report of 33 cases and review of the literature.
Journal of neurology, neurosurgery, and psychiatry 2002;72(1):59-67.
2002: Chatterjee Anjan; Fahn Stanley
Methylphenidate treats apathy in Parkinson's disease.
The Journal of neuropsychiatry and clinical neurosciences 2002;14(4):461-2.
2002: Fahn Stanley
The early history of paroxysmal dyskinesias.
Advances in neurology 2002;89():377-85.
2002: Frucht Steven J; Leurgans Sue E; Hallett Mark; Fahn Stanley
The Unified Myoclonus Rating Scale.
Advances in neurology 2002;89():361-76.
2002: Fahn Stanley
Overview, history, and classification of myoclonus.
Advances in neurology 2002;89():13-7.
2001: Lynch T; Sano M; Marder K S; Bell K L; Foster N L; Defendini R F; Sima A A; Keohane C; Nygaard T G; Fahn S; Mayeux R; Rowland L P; Wilhelmsen K C
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. 1994.
Neurology 2001;57(10 Suppl 3):S39-45.
2001: Louis E D; Levy G; Côte L J; Mejia H; Fahn S; Marder K
Clinical correlates of action tremor in Parkinson disease.
Archives of neurology 2001;58(10):1630-4.
2001: Frucht S J; Fahn S; Greene P E; O'Brien C; Gelb M; Truong D D; Welsh J; Factor S; Ford B
The natural history of embouchure dystonia.
Movement disorders : official journal of the Movement Disorder Society 2001;16(5):899-906.
2001: Frucht S J; Louis E D; Chuang C; Fahn S
A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus.
Neurology 2001;57(6):1112-4.
2001: Nakamura T; Dhawan V; Chaly T; Fukuda M; Ma Y; Breeze R; Greene P; Fahn S; Freed C; Eidelberg D
Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease.
Annals of neurology 2001;50(2):181-7.
2001: Giladi N; McDermott M P; Fahn S; Przedborski S; Jankovic J; Stern M; Tanner C;
Freezing of gait in PD: prospective assessment in the DATATOP cohort.
Neurology 2001;56(12):1712-21.
2001: Louis E D; Winfield L; Fahn S; Ford B
Speech dysfluency exacerbated by levodopa in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):562-5.
2001: Bressman S B; Fahn S; Ozelius L J; Kramer P L; Risch N J
The DYT1 mutation and nonfamilial primary torsion dystonia.
Archives of neurology 2001;58(4):681-2.
2001: Freed C R; Greene P E; Breeze R E; Tsai W Y; DuMouchel W; Kao R; Dillon S; Winfield H; Culver S; Trojanowski J Q; Eidelberg D; Fahn S
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
The New England journal of medicine 2001;344(10):710-9.
2001: Shoulson I; Penney J; McDermott M; Schwid S; Kayson E; Chase T; Fahn S; Greenamyre J T; Lang A; Siderowf A; Pearson N; Harrison M; Rost E; Colcher A; Lloyd M; Matthews M; Pahwa R; McGuire D; Lew M F; Schuman S; Marek K; Broshjeit S; Factor S; Brown D; Feigin A; Mazurkiewicz J; Ford B; Jennings D; Dilllon S; Comella C; Blasucci L; Janko K; Shulman L; Wiener W; Bateman-Rodriguez D; Carrion A; Suchowersky O; Lafontaine A L; Pantella C; Siemers E; Belden J; Davies R; Lannon M; Grimes D; Gray P; Martin W; Kennedy L; Adler C; Newman S; Hammerstad J; Stone C; Lewitt P; Bardram K; Mistura K; Miyasaki J; Johnston L; Cha J H; Tennis M; Panniset M; Hall J; Tetrud J; Friedlander J; Hauser R; Gauger L; Rodnitzky R; Deleo A; Dobson J; Seeberger L; Dingmann C; Tarsy D; Ryan P; Elmer L; Ruzicka D; Stacy M; Brewer M; Locke B; Baker D; Casaceli C; Day D; Florack M; Hodgeman K; Laroia N; Nobel R; Orme C; Rexo L; Rothenburgh K; Sulimowicz K; Watts A; Wratni E; Tariot P; Cox C; Leventhal C; Alderfer V; Craun A M; Frey J; McCree L; McDermott J; Cooper J; Holdich T; Read B;
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.
Neurology 2001;56(4):455-62.
2000: Thyagarajan D; Bressman S; Bruno C; Przedborski S; Shanske S; Lynch T; Fahn S; DiMauro S
A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy.
Annals of neurology 2000;48(5):730-6.
2000: Klein C; Schilling K; Saunders-Pullman R J; Garrels J; Breakefield X O; Brin M F; deLeon D; Doheny D; Fahn S; Fink J S; Forsgren L; Friedman J; Frucht S; Harris J; Holmgren G; Kis B; Kurlan R; Kyllerman M; Lang A E; Leung J; Raymond D; Robishaw J D; Sanner G; Schwinger E; Tabamo R E; Tagliati M
A major locus for myoclonus-dystonia maps to chromosome 7q in eight families.
American journal of human genetics 2000;67(5):1314-9.
2000: Frucht S J; Greene P E; Fahn S
Sleep episodes in Parkinson's disease: a wake-up call.
Movement disorders : official journal of the Movement Disorder Society 2000;15(4):601-3.
2000: Bressman S B; Sabatti C; Raymond D; de Leon D; Klein C; Kramer P L; Brin M F; Fahn S; Breakefield X; Ozelius L J; Risch N J
The DYT1 phenotype and guidelines for diagnostic testing.
Neurology 2000;54(9):1746-52.
2000: Fahn S
The spectrum of levodopa-induced dyskinesias.
Annals of neurology 2000;47(4 Suppl 1):S2-9; discussion S9-11.
2000: Frucht S; Fahn S; Ford B
Focal task-specific dystonia induced by peripheral trauma.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):348-50.
2000: Frucht S; Fahn S; Chin S; Dhawan V; Eidelberg D
Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):340-3.
2000: Furukawa Y; Hornykiewicz O; Fahn S; Kish S J
Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation.
Neurology 2000;54(5):1193-5.
2000: Freed C R; Breeze R E; Fahn S
Placebo surgery in trials of therapy for Parkinson's disease.
The New England journal of medicine 2000;342(5):353-4; author reply 354-5.
2000: Frucht S; Fahn S
The clinical spectrum of posthypoxic myoclonus.
Movement disorders : official journal of the Movement Disorder Society 2000;15 Suppl 1():2-7.
1999: Ozelius L J; Page C E; Klein C; Hewett J W; Mineta M; Leung J; Shalish C; Bressman S B; de Leon D; Brin M F; Fahn S; Corey D P; Breakefield X O
The TOR1A (DYT1) gene family and its role in early onset torsion dystonia.
Genomics 1999;62(3):377-84.
1999: Agid Y; Ahlskog E; Albanese A; Calne D; Chase T; De Yebenes J; Factor S; Fahn S; Gershanik O; Goetz C; Koller W; Kurth M; Lang A; Lees A; Lewitt P; Marsden D; Melamed E; Michel P P; Mizuno Y; Obeso J; Oertel W; Olanow W; Poewe W; Pollak P; Tolosa E
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):911-3.
1999: Frucht S; Fahn S; Ford B; Gelb M
A geste antagoniste device to treat jaw-closing dystonia.
Movement disorders : official journal of the Movement Disorder Society 1999;14(5):883-6.
1999: Frucht S; Fahn S
Paroxysmal kinesigenic dyskinesia in infancy.
Movement disorders : official journal of the Movement Disorder Society 1999;14(4):694-5.
1999: Frucht S; Rogers J D; Greene P E; Gordon M F; Fahn S
Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole.
Neurology 1999;52(9):1908-10.
1999: Fahn S
Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA.
Archives of neurology 1999;56(5):529-35.
1999: Saunders-Pullman R; Gordon-Elliott J; Parides M; Fahn S; Saunders H R; Bressman S
The effect of estrogen replacement on early Parkinson's disease.
Neurology 1999;52(7):1417-21.
1999: Klein C; Brin M F; Kramer P; Sena-Esteves M; de Leon D; Doheny D; Bressman S; Fahn S; Breakefield X O; Ozelius L J
Association of a missense change in the D2 dopamine receptor with myoclonus dystonia.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(9):5173-6.
1999: Frucht S; Fahn S; Shannon K M; Waters C H
A 32-year-old man with progressive spasticity and parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):350-7.
1999: Frucht S; Fahn S; Ford B
French horn embouchure dystonia.
Movement disorders : official journal of the Movement Disorder Society 1999;14(1):171-3.
1998: Fahn S
Medical treatment of Parkinson's disease.
Journal of neurology 1998;245(11 Suppl 3):P15-24.
1998: Lieberman A; Olanow C W; Sethi K; Swanson P; Waters C H; Fahn S; Hurtig H; Yahr M
A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group.
Neurology 1998;51(4):1057-62.
1998: Ford B; Louis E D; Greene P; Fahn S
Outcome of selective ramisectomy for botulinum toxin resistant torticollis.
Journal of neurology, neurosurgery, and psychiatry 1998;65(4):472-8.
1998: Fahn S; Clarence-Smith K E; Chase T N
Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventions--report of a workshop.
Movement disorders : official journal of the Movement Disorder Society 1998;13(5):759-67.
1998: Eidelberg D; Moeller J R; Antonini A; Kazumata K; Nakamura T; Dhawan V; Spetsieris P; deLeon D; Bressman S B; Fahn S
Functional brain networks in DYT1 dystonia.
Annals of neurology 1998;44(3):303-12.
1998: Tabbal S; Fahn S; Frucht S
Fetal tissue transplantation [correction of transplanation] in Parkinson's disease.
Current opinion in neurology 1998;11(4):341-9.
1998: Fahn S
Videotapes of motor complications of encephalitis lethargica.
Movement disorders : official journal of the Movement Disorder Society 1998;13(4):752-3.
1998: Hutton M; Lendon C L; Rizzu P; Baker M; Froelich S; Houlden H; Pickering-Brown S; Chakraverty S; Isaacs A; Grover A; Hackett J; Adamson J; Lincoln S; Dickson D; Davies P; Petersen R C; Stevens M; de Graaff E; Wauters E; van Baren J; Hillebrand M; Joosse M; Kwon J M; Nowotny P; Che L K; Norton J; Morris J C; Reed L A; Trojanowski J; Basun H; Lannfelt L; Neystat M; Fahn S; Dark F; Tannenberg T; Dodd P R; Hayward N; Kwok J B; Schofield P R; Andreadis A; Snowden J; Craufurd D; Neary D; Owen F; Oostra B A; Hardy J; Goate A; van Swieten J; Mann D; Lynch T; Heutink P
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.
Nature 1998;393(6686):702-5.
1998: Vatassery G T; Fahn S; Kuskowski M A
Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Parkinson Study Group.
Neurology 1998;50(6):1900-2.
1998: Dalvi A; Fahn S; Ford B
Intrathecal baclofen in the treatment of dystonic storm.
Movement disorders : official journal of the Movement Disorder Society 1998;13(3):611-2.
1998: Fahn S
Tolcapone: COMT inhibition for the treatment of Parkinson's disease.
Neurology 1998;50(5 Suppl 5):S1-2.
1998: Fahn S
Welcome news about levodopa, but uncertainty remains.
Annals of neurology 1998;43(5):551-4.
1998: Dauer W T; Burke R E; Greene P; Fahn S
Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia.
Brain : a journal of neurology 1998;121 ( Pt 4)():547-60.
1998: Marsden C D; Fahn S
Dystomia 3. Summary and conclusions.
Advances in neurology 1998;78():359-64.
1998: Wilhelmsen K C; Moskowitz C B; Weeks D E; Neystat M; Nygaard T G; Clark L; Dancoup M; Sobrevega E E; Rosales R; Gamez G L; Pacioles O; Perez M; Fahn S
Molecular genetic analysis of Lubag.
Advances in neurology 1998;78():341-8.
1998: Ford B; Greene P E; Louis E D; Bressman S B; Goodman R R; Brin M F; Sadiq S; Fahn S
Intrathecal baclofen in the treatment of dystonia.
Advances in neurology 1998;78():199-210.
1998: Bressman S B; de Leon D; Raymond D; Greene P E; Brin M F; Fahn S; Ozelius L J; Breakefield X O; Kramer P L; Risch N J
The role of the DYT1 gene in secondary dystonia.
Advances in neurology 1998;78():107-15.
1998: Ozelius L J; Hewett J W; Page C E; Bressman S B; Kramer P L; Shalish C; de Leon D; Brin M F; Raymond D; Jacoby D; Penney J; Risch N J; Fahn S; Gusella J F; Breakefield X O
The gene (DYT1) for early-onset torsion dystonia encodes a novel protein related to the Clp protease/heat shock family.
Advances in neurology 1998;78():93-105.
1998: Fahn S; Bressman S B; Marsden C D
Classification of dystonia.
Advances in neurology 1998;78():1-10.
1998: Fahn S; Elliott R
Highlights of the Parkinson's Disease Foundation.
Movement disorders : official journal of the Movement Disorder Society 1998;13 Suppl 1():2-6.
1998: Fahn S; Chouinard S
Experience with tranylcypromine in early Parkinson's disease.
Journal of neural transmission. Supplementum 1998;52():49-61.
1997: Chouinard S; Louis E D; Fahn S
Agreement among movement disorder specialists on the clinical diagnosis of essential tremor.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):973-6.
1997: Almasy L; Bressman S B; Raymond D; Kramer P L; Greene P E; Heiman G A; Ford B; Yount J; de Leon D; Chouinard S; Saunders-Pullman R; Brin M F; Kapoor R P; Jones A C; Shen H; Fahn S; Risch N J; Nygaard T G
Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families.
Annals of neurology 1997;42(4):670-3.
1997: Ozelius L J; Hewett J W; Page C E; Bressman S B; Kramer P L; Shalish C; de Leon D; Brin M F; Raymond D; Corey D P; Fahn S; Risch N J; Buckler A J; Gusella J F; Breakefield X O
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein.
Nature genetics 1997;17(1):40-8.
1997: Lynch T; Fahn S; Louis E D; Odel J G
Oculofacial-skeletal myorhythmia in Whipple's disease.
Movement disorders : official journal of the Movement Disorder Society 1997;12(4):625-6.
1997: Lynch T; Odel J; Fredericks D N; Louis E D; Forman S; Rotterdam H; Fahn S; Relman D A
Polymerase chain reaction-based detection of Tropheryma whippelii in central nervous system Whipple's disease.
Annals of neurology 1997;42(1):120-4.
1997: Bressman S B; de Leon D; Raymond D; Greene P E; Brin M F; Fahn S; Ozelius L J; Breakefield X O; Kramer P L; Risch N J
Secondary dystonia and the DYTI gene.
Neurology 1997;48(6):1571-7.
1997: Giladi N; Kao R; Fahn S
Freezing phenomenon in patients with parkinsonian syndromes.
Movement disorders : official journal of the Movement Disorder Society 1997;12(3):302-5.
1997: Ozelius L J; Hewett J; Kramer P; Bressman S B; Shalish C; de Leon D; Rutter M; Risch N; Brin M F; Markova E D; Limborska S A; Ivanova-Smolenskaya I A; McCormick M K; Fahn S; Buckler A J; Gusella J F; Breakefield X O
Fine localization of the torsion dystonia gene (DYT1) on human chromosome 9q34: YAC map and linkage disequilibrium.
Genome research 1997;7(5):483-94.
1997: Fahn S
An overview of novel therapies for Parkinson's disease.
Experimental neurology 1997;144(1):21-3.
1997: Kurlan R; Brin M F; Fahn S
Movement disorder in reflex sympathetic dystrophy: a case proven to be psychogenic by surveillance video monitoring.
Movement disorders : official journal of the Movement Disorder Society 1997;12(2):243-5.
1997: Louis E D; Klatka L A; Liu Y; Fahn S
Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease.
Neurology 1997;48(2):376-80.
1997: Tan A; Salgado M; Fahn S
The characterization and outcome of stereotypical movements in nonautistic children.
Movement disorders : official journal of the Movement Disorder Society 1997;12(1):47-52.
1997: Louis E D; Ottman R; Ford B; Pullman S; Martinez M; Fahn S; Hauser W A
The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research.
Neuroepidemiology 1997;16(3):124-33.
1996: Olanow C W; Fahn S; Langston J W; Godbold J
Selegiline and mortality in Parkinson's disease.
Annals of neurology 1996;40(6):841-5.
1996: Ford B; Greene P; Louis E D; Petzinger G; Bressman S B; Goodman R; Brin M F; Sadiq S; Fahn S
Use of intrathecal baclofen in the treatment of patients with dystonia.
Archives of neurology 1996;53(12):1241-6.
1996: Fahn S
Is levodopa toxic?
Neurology 1996;47(6 Suppl 3):S184-95.
1996: Bressman S B; Warner T T; Almasy L; Uitti R J; Greene P E; Heiman G A; Raymond D; Ford B; de Leon D; Fahn S; Kramer P L; Risch N J; Maraganore D M; Nygaard T G; Harding A E
Exclusion of the DYT1 locus in familial torticollis.
Annals of neurology 1996;40(4):681-4.
1996: Louis E D; Lynch T; Kaufmann P; Fahn S; Odel J
Diagnostic guidelines in central nervous system Whipple's disease.
Annals of neurology 1996;40(4):561-8.
1996: Pullman S L; Greene P; Fahn S; Pedersen S F
Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
Archives of neurology 1996;53(7):617-24.
1996: Erenberg G; Fahn S
Tourette syndrome.
Archives of neurology 1996;53(7):588.
1996: Ford B; Louis E D; Greene P; Fahn S
Oral and genital pain syndromes in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1996;11(4):421-6.
1996: Fahn S; Brin M F; Dwork A J; Weiner W J; Goetz C G; Rajput A H
Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma.
Movement disorders : official journal of the Movement Disorder Society 1996;11(3):298-310.
1996: Louis E D; Lynch T; Ford B; Greene P; Bressman S B; Fahn S
Delayed-onset cerebellar syndrome.
Archives of neurology 1996;53(5):450-4.
1996: Tan A; Salgado M; Fahn S
Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa.
Movement disorders : official journal of the Movement Disorder Society 1996;11(2):214-6.
1996: Louis E D; Lynch T; Marder K; Fahn S
Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale.
Movement disorders : official journal of the Movement Disorder Society 1996;11(2):185-92.
1996: Greene P E; Fahn S
Response to botulinum toxin F in seronegative botulinum toxin A--resistant patients.
Movement disorders : official journal of the Movement Disorder Society 1996;11(2):181-4.
1996: Pullman S L; Ford B; Elibol B; Uncini A; Su P C; Fahn S
Cutaneous electromyographic silent period findings in brachial dystonia.
Neurology 1996;46(2):503-8.
1996: Fahn S
Controversies in the therapy of Parkinson's disease.
Advances in neurology 1996;69():477-86.
1996: Louis E D; Fahn S
Pathologically diagnosed diffuse Lewy body disease and Parkinson's disease. Do the parkinsonian features differ?
Advances in neurology 1996;69():311-4.
1995: Eidelberg D; Moeller J R; Ishikawa T; Dhawan V; Spetsieris P; Przedborski S; Fahn S
The metabolic topography of idiopathic torsion dystonia.
Brain : a journal of neurology 1995;118 ( Pt 6)():1473-84.
1995: Louis E D; Lynch T; Cargan A L; Fahn S
Generalized chorea in an infant with semilobar holoprosencephaly.
Pediatric neurology 1995;13(4):355-7.
1995: Eidelberg D; Moeller J R; Ishikawa T; Dhawan V; Spetsieris P; Chaly T; Belakhlef A; Mandel F; Przedborski S; Fahn S
Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.
Neurology 1995;45(11):1995-2004.
1995: Stewart C; Winfield L; Hunt A; Bressman S B; Fahn S; Blitzer A; Brin M F
Speech dysfunction in early Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1995;10(5):562-5.
1995: Lang A E; Koller W C; Fahn S
Psychogenic parkinsonism.
Archives of neurology 1995;52(8):802-10.
1995: Holmgren G; Ozelius L; Forsgren L; Almay B G; Holmberg M; Kramer P; Fahn S; Breakefield X O
Adult onset idiopathic torsion dystonia is excluded from the DYT 1 region (9q34) in a Swedish family.
Journal of neurology, neurosurgery, and psychiatry 1995;59(2):178-81.
1995: Gordon M F; Bressman S; Brin M F; de Leon D; Warburton D; Yeboa K; Fahn S
Dystonia in a patient with deletion of 18q.
Movement disorders : official journal of the Movement Disorder Society 1995;10(4):496-9.
1995: McDermott M P; Jankovic J; Carter J; Fahn S; Gauthier S; Goetz C G; Golbe L I; Koller W; Lang A E; Olanow C W
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.
Archives of neurology 1995;52(6):565-70.
1995: Przedborski S; Jackson-Lewis V; Fahn S
Antiparkinsonian therapies and brain mitochondrial complex I activity.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):312-7.
1995: Goetz C G; Stebbins G T; Chmura T A; Fahn S; Klawans H L; Marsden C D
Teaching tape for the motor section of the unified Parkinson's disease rating scale.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):263-6.
1995: Louis E D; Goldman J E; Powers J M; Fahn S
Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):188-94.
1995: Greene P; Kang U J; Fahn S
Spread of symptoms in idiopathic torsion dystonia.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):143-52.
1995: Risch N; de Leon D; Ozelius L; Kramer P; Almasy L; Singer B; Fahn S; Breakefield X; Bressman S
Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population.
Nature genetics 1995;9(2):152-9.
1995: Fahn S
The freezing phenomenon in parkinsonism.
Advances in neurology 1995;67():53-63.
1995: Ford B; Fahn S; Pullman S L
Peripherally induced EMG silent periods. Normal physiology and disorders of motor control.
Advances in neurology 1995;67():321-8.
1995: Williams D T; Ford B; Fahn S
Phenomenology and psychopathology related to psychogenic movement disorders.
Advances in neurology 1995;65():231-57.
1994: Bressman S B; de Leon D; Kramer P L; Ozelius L J; Brin M F; Greene P E; Fahn S; Breakefield X O; Risch N J
Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation.
Annals of neurology 1994;36(5):771-7.
1994: Ford B; Greene P; Fahn S
Oral and genital tardive pain syndromes.
Neurology 1994;44(11):2115-9.
1994: Bressman S B; Hunt A L; Heiman G A; Brin M F; Burke R E; Fahn S; Trugman J M; de Leon D; Kramer P L; Wilhelmsen K C
Exclusion of the DYT1 locus in a non-Jewish family with early-onset dystonia.
Movement disorders : official journal of the Movement Disorder Society 1994;9(6):626-32.
1994: Fahn S; Mayeux R; Rowland L P
A new eponym: Wilhelmsen-Lynch disease.
Neurology 1994;44(10):1980.
1994: Lynch T; Sano M; Marder K S; Bell K L; Foster N L; Defendini R F; Sima A A; Keohane C; Nygaard T G; Fahn S
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex.
Neurology 1994;44(10):1878-84.
1994: Pullman S L; Elibol B; Fahn S
Modulation of parkinsonian tremor by radial nerve palsy.
Neurology 1994;44(10):1861-4.
1994: Przedborski S; Giladi N; Takikawa S; Ishikawa T; Dhawan V; Spetsieris P; Chaly T; Fahn S; Eidelberg D
Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
Neurology 1994;44(9):1622-8.
1994: Ford B; Fahn S
Intrathecal baclofen.
Neurology 1994;44(7):1367-8.
1994: Lew M F; Shindo M; Moskowitz C B; Wilhelmsen K C; Fahn S; Waters C H
Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).
Movement disorders : official journal of the Movement Disorder Society 1994;9(3):318-20.
1994: Greene P; Fahn S; Diamond B
Development of resistance to botulinum toxin type A in patients with torticollis.
Movement disorders : official journal of the Movement Disorder Society 1994;9(2):213-7.
1994: Wahlström J; Ozelius L; Kramer P; Kyllerman M; Schuback D; Forsgren L; Holmgren G; Drugge U; Sanner G; Fahn S
The gene for familial dystonia with myoclonic jerks responsive to alcohol is not located on the distal end of 9q.
Clinical genetics 1994;45(2):88-92.
1994: Lynch T; Burke R E; Fahn S
Progress in psychiatry.
The New England journal of medicine 1994;330(4):285-6.
1994: Olanow C W; Fahn S; Muenter M; Klawans H; Hurtig H; Stern M; Shoulson I; Kurlan R; Grimes J D; Jankovic J
A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1994;9(1):40-7.
1994: Rogers J D; Fahn S
Movement disorders and pregnancy.
Advances in neurology 1994;64():163-78.
1993: Nygaard T G; Wilhelmsen K C; Risch N J; Brown D L; Trugman J M; Gilliam T C; Fahn S; Weeks D E
Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q.
Nature genetics 1993;5(4):386-91.
1993: Przedborski S; Jackson-Lewis V; Muthane U; Jiang H; Ferreira M; Naini A B; Fahn S
Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity.
Annals of neurology 1993;34(5):715-23.
1993: Gordon M F; Diaz-Olivo R; Hunt A L; Fahn S
Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disorders.
Movement disorders : official journal of the Movement Disorder Society 1993;8(4):484-8.
1993: Greene P E; Fahn S
Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A.
Movement disorders : official journal of the Movement Disorder Society 1993;8(4):479-83.
1993: Eidelberg D; Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Margouleff D; Moeller J R; Patlak C S; Fahn S
Striatal 18F-dopa uptake: absence of an aging effect.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1993;13(5):881-8.
1993: Waters C H; Takahashi H; Wilhelmsen K C; Shubin R; Snow B J; Nygaard T G; Moskowitz C B; Fahn S; Calne D B
Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two women.
Neurology 1993;43(8):1555-8.
1993: Waters C H; Faust P L; Powers J; Vinters H; Moskowitz C; Nygaard T; Hunt A L; Fahn S
Neuropathology of lubag (x-linked dystonia parkinsonism).
Movement disorders : official journal of the Movement Disorder Society 1993;8(3):387-90.
1993: Pardo B; Mena M A; Fahn S; García de Yébenes J
Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line.
Movement disorders : official journal of the Movement Disorder Society 1993;8(3):278-84.
1993: Dwork A J; Balmaceda C; Fazzini E A; MacCollin M; Côté L; Fahn S
Dominantly inherited, early-onset parkinsonism: neuropathology of a new form.
Neurology 1993;43(1):69-74.
1993: Greene P; Cote L; Fahn S
Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
Advances in neurology 1993;60():703-6.
1993: Fahn S
Future strategies for the treatment of Parkinson's disease.
Advances in neurology 1993;60():636-40.
1993: Przedborski S; Goldman S; Giladi N; Dhawan V; Takikawa S; Hildebrand J; Fahn S; Eidelberg D
Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
Advances in neurology 1993;60():501-5.
1992: Fahn S; Cohen G
The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
Annals of neurology 1992;32(6):804-12.
1992: Nygaard T G; Takahashi H; Heiman G A; Snow B J; Fahn S; Calne D B
Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia.
Annals of neurology 1992;32(5):603-8.
1992: Fahn S
Fetal-tissue transplants in Parkinson's disease.
The New England journal of medicine 1992;327(22):1589-90.
1992: Giladi N; Fahn S
Hemiparkinsonism-hemiatrophy syndrome may mimic early-stage cortical-basal ganglionic degeneration.
Movement disorders : official journal of the Movement Disorder Society 1992;7(4):384-5.
1992: Gasser T; Fahn S; Breakefield X O
The autosomal dominant dystonias.
Brain pathology (Zurich, Switzerland) 1992;2(4):297-308.
1992: Russman B S; Lang A E; Fahn S; Greene P; Grunnet M L
What is it? Case 1, 1992: progressive gait deterioration, peripheral neuropathy, optic atrophy, bradykinesia, and dystonia in a young girl.
Movement disorders : official journal of the Movement Disorder Society 1992;7(4):373-9.
1992: Lang A; Quinn N; Marsden C D; Findley L; Koller W; Brin M; Fahn S
Essential tremor.
Neurology 1992;42(7):1432-4.
1992: Zhu S M; Kujirai K; Dollison A; Angulo J; Fahn S; Cadet J L
Implantation of genetically modified mesencephalic fetal cells into the rat striatum.
Brain research bulletin 1992;29(1):81-93.
1992: Przedborski S; Kostic V; Jackson-Lewis V; Naini A B; Simonetti S; Fahn S; Carlson E; Epstein C J; Cadet J L
Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1992;12(5):1658-67.
1992: Blitzer A; Brin M F; Stewart C; Aviv J E; Fahn S
Abductor laryngeal dystonia: a series treated with botulinum toxin.
The Laryngoscope 1992;102(2):163-7.
1992: Giladi N; McMahon D; Przedborski S; Flaster E; Guillory S; Kostic V; Fahn S
Motor blocks in Parkinson's disease.
Neurology 1992;42(2):333-9.
1992: Greene P E; Fahn S
Baclofen in the treatment of idiopathic dystonia in children.
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):48-52.
1992: Mena M A; Pardo B; Casarejos M J; Fahn S; García de Yébenes J
Neurotoxicity of levodopa on catecholamine-rich neurons.
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):23-31.
1992: Langston J W; Widner H; Goetz C G; Brooks D; Fahn S; Freeman T; Watts R
Core assessment program for intracerebral transplantations (CAPIT).
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):2-13.
1992: Fahn S
A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease.
Annals of neurology 1992;32 Suppl():S128-32.
1992: Fazzini E; Fleming J; Fahn S
Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1992;7(2):153-8.
1991: Giladi N; Greene P; Fahn S
[Botulinum toxin as a powerful new tool in the treatment of focal dystonia]
Harefuah 1991;121(11):475-8.
1991: Eidelberg D; Dhawan V; Moeller J R; Sidtis J J; Ginos J Z; Strother S C; Cederbaum J; Greene P; Fahn S; Powers J M
The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
Journal of neurology, neurosurgery, and psychiatry 1991;54(10):856-62.
1991: Kwiatkowski D J; Ozelius L; Kramer P L; Perman S; Schuback D E; Gusella J F; Fahn S; Breakefield X O
Torsion dystonia genes in two populations confined to a small region on chromosome 9q32-34.
American journal of human genetics 1991;49(2):366-71.
1991: Blitzer A; Brin M F; Fahn S
Botulinum toxin injections for lingual dystonia.
The Laryngoscope 1991;101(7 Pt 1):799.
1991: Lange D J; Rubin M; Greene P E; Kang U J; Moskowitz C B; Brin M F; Lovelace R E; Fahn S
Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes.
Muscle & nerve 1991;14(7):672-5.
1991: Kujirai K; Fahn S; Cadet J L
Receptor autoradiography of mu and delta opioid peptide receptors in spontaneously hypertensive rats.
Peptides 1991;12(4):779-85.
1991: Przedborski S; Levivier M; Kostic V; Jackson-Lewis V; Dollison A; Gash D M; Fahn S; Cadet J L
Sham transplantation protects against 6-hydroxydopamine-induced dopaminergic toxicity in rats: behavioral and morphological evidence.
Brain research 1991;550(2):231-8.
1991: Saint Hilaire M H; Burke R E; Bressman S B; Brin M F; Fahn S
Delayed-onset dystonia due to perinatal or early childhood asphyxia.
Neurology 1991;41(2 ( Pt 1)):216-22.
1991: Nygaard T G; Marsden C D; Fahn S
Dopa-responsive dystonia: long-term treatment response and prognosis.
Neurology 1991;41(2 ( Pt 1)):174-81.
1991: Jackson-Lewis V; Przedborski S; Kostic V; Suber F; Fahn S; Cadet J L
Partial attenuation of chronic fluphenazine-induced changes in regional monoamine metabolism by D-alpha-tocopherol in rat brain.
Brain research bulletin 1991;26(2):251-8.
1991: Wilhelmsen K C; Weeks D E; Nygaard T G; Moskowitz C B; Rosales R L; dela Paz D C; Sobrevega E E; Fahn S; Gilliam T C
Genetic mapping of "Lubag" (X-linked dystonia-parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome.
Annals of neurology 1991;29(2):124-31.
1991: Fahn S
An open trial of high-dosage antioxidants in early Parkinson's disease.
The American journal of clinical nutrition 1991;53(1 Suppl):380S-382S.
1991: Fahn S
The genetics of idiopathic torsion dystonia.
International journal of neurology 1991;25-26():70-80.
1991: Chan J; Brin M F; Fahn S
Idiopathic cervical dystonia: clinical characteristics.
Movement disorders : official journal of the Movement Disorder Society 1991;6(2):119-26.
1991: Fahn S; Sjaastad O
Hereditary essential myoclonus in a large Norwegian family.
Movement disorders : official journal of the Movement Disorder Society 1991;6(3):237-47.
1991: Przedborski S; Jackson-Lewis V; Popilskis S; Kostic V; Levivier M; Fahn S; Cadet J L
Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites.
Neuro-Chirurgie 1991;37(6):377-82.
1991: Micheli F; Fernandez Pardal M; Giannaula R; Fahn S
What is it? Case 3, 1991: moaning in a man with parkinsonian signs.
Movement disorders : official journal of the Movement Disorder Society 1991;6(4):376-8.
1991: Vecht C J; Meerwaldt J D; Lees A J; Marsden C D; Fahn S
What is it? Case 2, 1991: unusual tremor, myoclonus, and a limping gait.
Movement disorders : official journal of the Movement Disorder Society 1991;6(4):371-5.
1991: Pezzoli G; Zecchinelli A; Ricciardi S; Burke R E; Fahn S; Scarlato G; Carenzi A
Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats.
Movement disorders : official journal of the Movement Disorder Society 1991;6(4):281-7.
1990: Giladi N; Burke R E; Kostic V; Przedborski S; Gordon M; Hunt A; Fahn S
Hemiparkinsonism-hemiatrophy syndrome: clinical and neuroradiologic features.
Neurology 1990;40(11):1731-4.
1990: Kujirai K; Przedborski S; Kostic V; Jackson-Lewis V; Fahn S; Cadet J L
Autoradiography of dopamine receptors and dopamine uptake sites in the spontaneously hypertensive rat.
Brain research bulletin 1990;25(5):703-9.
1990: Park D H; Kang U J; Moskowitz C B; Burke R E; Joh T H; Fahn S
Dopamine beta-hydroxylase activity in cerebrospinal fluid of idiopathic torsion dystonia.
Neurology 1990;40(10):1626-8.
1990: Przedborski S; Wright M; Fahn S; Cadet J L
Quantitative autoradiographic changes in 5-[3H]HT-labeled 5-HT1 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN).
Neuroscience letters 1990;116(1-2):51-7.
1990: Greene P; Kang U; Fahn S; Brin M; Moskowitz C; Flaster E
Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis.
Neurology 1990;40(8):1213-8.
1990: Risch N J; Bressman S B; deLeon D; Brin M F; Burke R E; Greene P E; Shale H; Claus E B; Cupples L A; Fahn S
Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance.
American journal of human genetics 1990;46(3):533-8.
1990: Nygaard T G; Trugman J M; de Yebenes J G; Fahn S
Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family.
Neurology 1990;40(1):66-9.
1990: Fahn S; Burke R; Stern Y
Antimuscarinic drugs in the treatment of movement disorders.
Progress in brain research 1990;84():389-97.
1990: Greene P E; Fahn S; Lang A E; Watts R L; Eidelberg D; Powers J M
What is it? Case 1, 1990: progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb.
Movement disorders : official journal of the Movement Disorder Society 1990;5(4):341-51.
1990: Eidelberg D; Moeller J R; Dhawan V; Sidtis J J; Ginos J Z; Strother S C; Cedarbaum J; Greene P; Fahn S; Rottenberg D A
The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.
Movement disorders : official journal of the Movement Disorder Society 1990;5(3):203-13.
1990: de Yébenes J G; Fahn S; Goodman R; Jamrosik Z; Pezzoli G; Popalski S
Intracerebroventricular infusion of (+)-4-propyl-9-hydroxy-naphthoxacine in monkeys with MPTP-induced akinesia.
Advances in neurology 1990;53():231-8.
1989: Przedborski S; Wright M; Fahn S; Cadet J L
Autoradiographic evidence of [3H]neurotensin binding changes in discrete regions of brain in the rat model of persistent spasmodic dyskinesia induced by iminodipropionitrile.
Neuroscience letters 1989;107(1-3):335-40.
1989: Przedborski S; Wright M; Fahn S; Cadet J L
Regional changes in brain 5-HT1A serotonin receptors in the rat model of persistent spasmodic dyskinesias induced by iminodipropionitrile.
Brain research 1989;504(2):311-4.
1989: Perumal A S; Tordzro W K; Katz M; Jackson-Lewis V; Cooper T B; Fahn S; Cadet J L
Regional effects of 6-hydroxydopamine (6-OHDA) on free radical scavengers in rat brain.
Brain research 1989;504(1):139-41.
1989: Bressman S B; de Leon D; Brin M F; Risch N; Burke R E; Greene P E; Shale H; Fahn S
Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance.
Annals of neurology 1989;26(5):612-20.
1989: Fahn S
Clinical variants of idiopathic torsion dystonia.
Journal of neurology, neurosurgery, and psychiatry 1989;Suppl():96-100.
1989: Mena M A; Garcia de Yebenes J; Dwork A; Fahn S; Latov N; Herbert J; Flaster E; Slonim D
Biochemical properties of monoamine-rich human neuroblastoma cells.
Brain research 1989;486(2):286-96.
1989: Truong D D; Galloway M P; Pezzoli G; Jamrozik Z; Fahn S
Milacemide increases 5-hydroxytryptamine and dopamine levels in rat brain--possible mechanisms of milacemide antimyoclonic property in the p,p'-DDT-induced myoclonus.
Pharmacology, biochemistry, and behavior 1989;32(4):993-1001.
1989: Stennett R; Katz M; Jackson-Lewis V; Fahn S; Cadet J L
The protein synthesis inhibitor, anisomycin, causes exacerbation of the iminodipropionitrile-induced spasmodic dyskinetic syndrome in rats.
Pharmacology, biochemistry, and behavior 1989;32(4):1003-8.
1989: Blitzer A; Brin M F; Greene P E; Fahn S
Botulinum toxin injection for the treatment of oromandibular dystonia.
The Annals of otology, rhinology, and laryngology 1989;98(2):93-7.
1989: Thomas J; Jackson-Lewis V; Fahn S; Cadet J L
Methylprednisolone treatments alter apomorphine-induced circling in the rat model of 6-hydroxydopamine-induced striatal denervation.
The International journal of neuroscience 1989;44(1-2):149-54.
1989: Cadet J L; Katz M; Jackson-Lewis V; Fahn S
Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence.
Brain research 1989;476(1):10-5.
1989: Brin M F; Blitzer A; Fahn S; Gould W; Lovelace R E
Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
Movement disorders : official journal of the Movement Disorder Society 1989;4(4):287-96.
1989: Truong D D; Diamond B; Pezzoli G; Mena M A; Fahn S
Monoamine oxidase inhibitory properties of milacemide in rats.
Life sciences 1989;44(15):1059-66.
1989: Fahn S
The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high-dosage antioxidants in an attempt to slow the progression of the illness.
Annals of the New York Academy of Sciences 1989;570():186-96.
1989: Fahn S
The history of parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 1989;4 Suppl 1():S2-10.
1989: Burke R E; Kang U J; Jankovic J; Miller L G; Fahn S
Tardive akathisia: an analysis of clinical features and response to open therapeutic trials.
Movement disorders : official journal of the Movement Disorder Society 1989;4(2):157-75.
1989: Kang U J; Fahn S; Schwarz H; Shoulson I; Vallejos H; Goldman J
Case 1, 1989: juvenile-onset parkinsonism, dystonia, and pyramidal tract signs.
Movement disorders : official journal of the Movement Disorder Society 1989;4(4):363-70.
1988: Garcia de Yebenes J; Fahn S; Mena M A; Pardo B; Casarejos M J
Intracerebroventricular infusion of dopamine and its agonists in rodents and primates. An experimental approach to the treatment of Parkinson's disease.
ASAIO transactions / American Society for Artificial Internal Organs 1988;34(4):951-7.
1988: Pezzoli G; Fahn S; Dwork A; Truong D D; de Yebenes J G; Jackson-Lewis V; Herbert J; Cadet J L
Non-chromaffin tissue plus nerve growth factor reduces experimental parkinsonism in aged rats.
Brain research 1988;459(2):398-403.
1988: Troung D D; Bressman S; Shale H; Fahn S
Clonazepam, haloperidol, and clonidine in tic disorders.
Southern medical journal 1988;81(9):1103-5.
1988: Vatassery G T; Brin M F; Fahn S; Kayden H J; Traber M G
Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats.
Journal of neurochemistry 1988;51(2):621-3.
1988: Kang U J; Fahn S
Management of tardive dyskinesia.
Rational drug therapy 1988;22(8):1-7.
1988: Cadet J L; Jackson-Lewis V; Fahn S
The iminodipropionitrile (IDPN) model of persistent spasmodic dyskinesias: regional serotonin metabolism in rat brain.
Brain research 1988;456(2):371-4.
1988: Blitzer A; Brin M F; Fahn S; Lovelace R E
Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases.
The Laryngoscope 1988;98(6 Pt 1):636-40.
1988: Mayeux R; Stern Y; Rosenstein R; Marder K; Hauser A; Cote L; Fahn S
An estimate of the prevalence of dementia in idiopathic Parkinson's disease.
Archives of neurology 1988;45(3):260-2.
1988: Fahn S
Is the thought disorder with oculogyric crisis a feature of tardive akathisia or tardive dysphrenia?
Annals of neurology 1988;23(3):313-4.
1988: Blitzer A; Brin M F; Fahn S; Lovelace R E
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia).
The Laryngoscope 1988;98(2):193-7.
1988: Truong D D; Sczesni B; Fahn S; Gross J; Donovan K; van Bakel A; Wiley M K
[Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases]
Der Nervenarzt 1988;59(2):103-9.
1988: Cadet J L; Clark C R; Fahn S
Behavioral effects of alpha-benzyl-N-methylphenethylamine (ABNMP), a methamphetamine analog: inhibition by ketanserin and para-chlorophenylalanine (PCPA).
Pharmacology, biochemistry, and behavior 1988;29(1):125-8.
1988: Falk C T; Bressman S B; Allen F H; Moskowitz C; Fahn S; Brin M
Linkage studies in families with dystonia: linkage analysis as a tool to locate and characterize the gene(s) for dystonia.
Advances in neurology 1988;50():67-72.
1988: Brin M F; Fahn S; Moskowitz C; Friedman A; Shale H M; Greene P E; Blitzer A; List T; Lange D; Lovelace R E
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
Advances in neurology 1988;50():599-608.
1988: Greene P; Shale H; Fahn S
Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia.
Advances in neurology 1988;50():547-56.
1988: Bressman S B; de Leon D; Brin M F; Risch N; Shale H; Burke R E; Greene P E; Fahn S
Inheritance of idiopathic torsion dystonia among Ashkenazi Jews.
Advances in neurology 1988;50():45-56.
1988: Fahn S; Williams D T
Psychogenic dystonia.
Advances in neurology 1988;50():431-55.
1988: Kang U J; Burke R E; Fahn S
Tardive dystonia.
Advances in neurology 1988;50():415-29.
1988: Bressman S B; Fahn S; Burke R E
Paroxysmal non-kinesigenic dystonia.
Advances in neurology 1988;50():403-13.
1988: Rutledge J N; Hilal S K; Silver A J; Defendini R; Fahn S
Magnetic resonance imaging of dystonic states.
Advances in neurology 1988;50():265-75.
1988: Ruberg M; Villageois A; Bonnet A M; Rieger F; Agid Y; Fahn S
Acetylcholinesterase and butyrylcholinesterase in cerebrospinal fluid from patients with dystonia.
Advances in neurology 1988;50():211-3.
1988: de Yebenes J G; Moskowitz C; Fahn S; Saint-Hilaire M H
Long-term treatment with levodopa in a family with autosomal dominant torsion dystonia.
Advances in neurology 1988;50():101-11.
1988: Fahn S
Blepharospasm: a form of focal dystonia.
Advances in neurology 1988;49():125-33.
1988: Shale H; Fahn S; Calne D B
Case 1, 1988. Head tilt in a young girl associated with neck pain and limitation of neck movement.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):347-51.
1988: Truong D D; Garcia De Yebenes J; Pezzoli G; Jackson-Lewis V; Fahn S
Glycine involvement in DDT-induced myoclonus.
Movement disorders : official journal of the Movement Disorder Society 1988;3(1):77-87.
1988: de Yebenes J G; Fahn S; Jackson-Lewis V; Jorge P; Mena M A; Reiriz J
Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease.
Journal of neural transmission. Supplementum 1988;27():141-60.
1988: Truong D D; Fahn S
Therapeutic trial with glycine in myoclonus.
Movement disorders : official journal of the Movement Disorder Society 1988;3(3):222-32.
1988: Greene P; Shale H; Fahn S
Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs.
Movement disorders : official journal of the Movement Disorder Society 1988;3(1):46-60.
1988: Truong D D; Fahn S
An early description of dystonia: translation of Schwalbe's thesis and information on his life.
Advances in neurology 1988;50():651-64.
1988: Fahn S
Concept and classification of dystonia.
Advances in neurology 1988;50():1-8.
1988: de Yebenes J G; Brin M F; Mena M A; De Felipe C; del Rio R M; Bazan E; Martinez A; Fahn S; Del Rio J; Vazquez A
Neurochemical findings in neuroacanthocytosis.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):300-12.
1988: Kramer P L; Ozelius L; Brin M F; Fahn S; Kidd K K; Gusella J; Breakefield X O
Molecular genetics of an autosomal dominant form of torsion dystonia.
Advances in neurology 1988;50():57-66.
1988: Tolosa E; Kulisevsky J; Fahn S
Meige syndrome: primary and secondary forms.
Advances in neurology 1988;50():509-15.
1988: Burke R E; Fahn S
An evaluation of sustained postural abnormalities in rats induced by intracerebro-ventricular injection of chlorpromazine methiodide or somatostatin as models of dystonia.
Advances in neurology 1988;50():335-42.
1988: Brin M F; Moskowitz C; Fahn S
Dystonia clinical research center tissue resource facility: investigations on collected tissue.
Advances in neurology 1988;50():215-22.
1988: Lange D J; Brin M F; Fahn S; Lovelace R E
Distant effects of locally injected botulinum toxin: incidence and course.
Advances in neurology 1988;50():609-13.
1987: Cadet J L; Kuyatt B; Fahn S; De Souza E B
Differential changes in 125I-LSD-labeled 5-HT-2 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN): evidence from autoradiographic studies.
Brain research 1987;437(2):383-6.
1987: Gollomp S M; Fahn S
Transient dystonia as a complication of varicella.
Journal of neurology, neurosurgery, and psychiatry 1987;50(9):1228-9.
1987: García de Yébenes J; Fahn S
[New therapeutic alternatives in Parkinson disease]
Neurología (Barcelona, Spain) 1987;2(5):199-201.
1987: Fahn S
Systemic therapy of dystonia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1987;14(3 Suppl):528-32.
1987: Rutledge J N; Hilal S K; Silver A J; Defendini R; Fahn S
Study of movement disorders and brain iron by MR.
AJR. American journal of roentgenology 1987;149(2):365-79.
1987: Lange D J; Brin M F; Warner C L; Fahn S; Lovelace R E
Distant effects of local injection of botulinum toxin.
Muscle & nerve 1987;10(6):552-5.
1987: Fahn S
Drug treatment of hyperkinetic movement disorders.
Seminars in neurology 1987;7(2):192-208.
1987: Fahn S
Paroxysmal myoclonic dystonia with vocalisations.
Journal of neurology, neurosurgery, and psychiatry 1987;50(1):117-8.
1987: Kramer P L; Ozelius L; Gusella J F; Fahn S; Kidd K K; Breakefield X O
Exclusion of autosomal dominant dystonia gene from large regions of chromosomes 11p, 13q, and 21q by multi-point linkage analysis.
Genetic epidemiology 1987;4(5):377-86.
1987: Shale H; Fahn S; Koller W C; Lang A E
What is it? Case 1, 1987: unusual tremors, bradykinesia, and cerebral lucencies.
Movement disorders : official journal of the Movement Disorder Society 1987;2(4):321-38.
1987: Brin M F; Fahn S; Moskowitz C; Friedman A; Shale H M; Greene P E; Blitzer A; List T; Lange D; Lovelace R E
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
Movement disorders : official journal of the Movement Disorder Society 1987;2(4):237-54.
1987: de Yebenes J G; Fahn S; Jackson-Lewis V; Mena M A
The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiency.
Movement disorders : official journal of the Movement Disorder Society 1987;2(4):291-9.
1987: de Yebenes J G; Fahn S; Lovelle S; Jackson-Lewis V; Jorge P; Mena M A; Reiriz J; Bustos J C; Magariños C; Martinez A
Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1987;2(3):143-58.
1986: Mayeux R; Stern Y; Herman A; Greenbaum L; Fahn S
Correlates of early disability in Huntington's disease.
Annals of neurology 1986;20(6):727-31.
1986: Blitzer A; Brin M F; Fahn S; Lange D; Lovelace R E
Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias.
The Laryngoscope 1986;96(11):1300-1.
1986: Hening W A; Walters A; Kavey N; Gidro-Frank S; Côté L; Fahn S
Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids.
Neurology 1986;36(10):1363-6.
1986: Traub M; Reches A; Wagner H R; Fahn S
Reserpine-induced up-regulation of dopamine D2 receptors in the rat striatum is enhanced by denervation but not by chronic receptor blockade.
Neuroscience letters 1986;70(2):245-9.
1986: Hassan M N; Higgins D; Traub M; Fahn S
Chronic treatment with bromocriptine induces behavioral supersensitivity in rats.
Life sciences 1986;39(6):513-8.
1986: Friedman A; Fahn S
Spontaneous remissions in spasmodic torticollis.
Neurology 1986;36(3):398-400.
1986: Burke R E; Fahn S; Marsden C D
Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl.
Neurology 1986;36(2):160-4.
1986: Walters A; Hening W; Côté L; Fahn S
Dominantly inherited restless legs with myoclonus and periodic movements of sleep: a syndrome related to the endogenous opiates?
Advances in neurology 1986;43():309-19.
1986: Bressman S; Fahn S; Eisenberg M; Brin M; Maltese W
Biotin-responsive encephalopathy with myoclonus, ataxia, and seizures.
Advances in neurology 1986;43():119-25.
1986: Fahn S; Marsden C D; Van Woert M H
Definition and classification of myoclonus.
Advances in neurology 1986;43():1-5.
1986: Hassan M N; Reches A; Kuhn C; Higgins D; Fahn S
Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide.
Clinical neuropharmacology 1986;9(1):71-8.
1986: Fahn S
Generalized dystonia: concept and treatment.
Clinical neuropharmacology 1986;9 Suppl 2():S37-48.
1986: Burke R E; Brin M F; Fahn S; Bressman S B; Moskowitz C
Analysis of the clinical course of non-Jewish, autosomal dominant torsion dystonia.
Movement disorders : official journal of the Movement Disorder Society 1986;1(3):163-78.
1986: Fahn S; Marsden C D
The video medium creates new responsibilities and opportunities.
Movement disorders : official journal of the Movement Disorder Society 1986;1(2):91-2.
1986: Shale H; Fahn S; Mayeux R
Tics in a patient with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1986;1(1):79-83.
1986: Jankovic J; Fahn S
The phenomenology of tics.
Movement disorders : official journal of the Movement Disorder Society 1986;1(1):17-26.
1986: Bressman S; Fahn S
Essential myoclonus.
Advances in neurology 1986;43():287-94.
1986: Fahn S
Posthypoxic action myoclonus: literature review update.
Advances in neurology 1986;43():157-69.
1986: Kang U J; Burke R E; Fahn S
Natural history and treatment of tardive dystonia.
Movement disorders : official journal of the Movement Disorder Society 1986;1(3):193-208.
1986: Walters A; Hening W; Chokroverty S; Fahn S
Opioid responsiveness in patients with neuroleptic-induced akathisia.
Movement disorders : official journal of the Movement Disorder Society 1986;1(2):119-27.
1986: Wagner H R; Reches A; Yablonskaya E; Fahn S
Clonazepam-induced up-regulation of serotonin1 and serotonin2 binding sites in rat frontal cortex.
Advances in neurology 1986;43():645-51.
1986: Fahn S
Newer drugs for posthypoxic action myoclonus: observations from a well-studied case.
Advances in neurology 1986;43():197-9.
1985: Burke R E; Fahn S
The effect of selective lesions on vestibular nuclear complex choline acetyltransferase activity in the rat.
Brain research 1985;360(1-2):172-82.
1985: Blitzer A; Lovelace R E; Brin M F; Fahn S; Fink M E
Electromyographic findings in focal laryngeal dystonia (spastic dysphonia).
The Annals of otology, rhinology, and laryngology 1985;94(6 Pt 1):591-4.
1985: Reches A; Jackson-Lewis V; Fahn S
DL-threo-DOPS as a precursor of noradrenaline.
Naunyn-Schmiedeberg's archives of pharmacology 1985;331(2-3):202-8.
1985: Traub M; Wagner H R; Hassan M; Jackson-Lewis V; Fahn S
The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.
European journal of pharmacology 1985;118(1-2):147-54.
1985: Reches A; Wagner H R; Jackson-Lewis V; Fahn S
Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockade.
Brain research 1985;347(2):346-9.
1985: Fahn S
Lack of benefit from cervical cord stimulation for dystonia.
The New England journal of medicine 1985;313(19):1229.
1985: Wagner H R; Reches A; Fahn S
Clonazepam-induced up-regulation of serotonin1 binding sites in frontal cortex of rat.
Neuropharmacology 1985;24(10):953-6.
1985: Burke R E; Fahn S
Pharmacokinetics of trihexyphenidyl after short-term and long-term administration to dystonic patients.
Annals of neurology 1985;18(1):35-40.
1985: Burke R E; Fahn S
Serum trihexyphenidyl levels in the treatment of torsion dystonia.
Neurology 1985;35(7):1066-9.
1985: Reches A; Liu K P; Karpiak S E; Fahn S; Cooper T B; Suckow R; Jackson V; Tamir H
Serotonin depletion induced by reserpine is attenuated by prophylactic administration of lithium.
European journal of pharmacology 1985;113(2):225-31.
1985: Fahn S
A therapeutic approach to tardive dyskinesia.
The Journal of clinical psychiatry 1985;46(4 Pt 2):19-24.
1985: Maltese W A; Bressman S; Fahn S; De Vivo D C
Acetylcholinesterase activity in patients with torsion dystonia. Measurement in erythrocyte membranes.
Archives of neurology 1985;42(2):154-5.
1985: Burke R E; Reches A; Traub M M; Ilson J; Swash M; Fahn S
Tetrabenazine induces acute dystonic reactions.
Annals of neurology 1985;17(2):200-2.
1985: Burke R E; Fahn S
Choline acetyltransferase activity of the principal vestibular nuclei of rat, studied by micropunch technique.
Brain research 1985;328(1):196-9.
1985: Burke R E; Fahn S; Marsden C D; Bressman S B; Moskowitz C; Friedman J
Validity and reliability of a rating scale for the primary torsion dystonias.
Neurology 1985;35(1):73-7.
1985: Barkai A I; Kowalik S; Reches A; Cooper T B; Fahn S
Attenuation by electroshock treatment of the haloperidol-induced rise in the binding of 3H-imipramine to rat brain membranes.
Psychopharmacology 1985;86(4):400-3.
1984: Crider A M; Hemdi T F; Hassan M N; Fahn S
Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide.
Journal of pharmaceutical sciences 1984;73(11):1585-7.
1984: Bressman S B; Fahn S; Falk C; Allen F H; Suciu-Foca N
Genetic linkage analysis in primary torsion dystonia.
Neurology 1984;34(11):1490-3.
1984: Reches A; Wagner H R; Jackson-Lewis V; Yablonskaya-Alter E; Fahn S
Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum.
Neurology 1984;34(9):1208-12.
1984: Walters A; Jackson-Lewis V; Fahn S
Little effect of dimethyl sulfoxide on blood-brain barrier to dopamine.
Experientia 1984;40(8):859-61.
1984: Fahn S; Jankovic J
Practical management of dystonia.
Neurologic clinics 1984;2(3):555-69.
1984: Fahn S
The varied clinical expressions of dystonia.
Neurologic clinics 1984;2(3):541-54.
1984: Bodnar R J; Kordower J H; Reches A; Wallace M M; Fahn S
Reductions in pain thresholds and morphine analgesia following intracerebroventricular parachlorophenylalanine.
Pharmacology, biochemistry, and behavior 1984;21(1):79-84.
1984: Jiang D H; Reches A; Wagner H R; Fahn S
Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brain.
Neuropharmacology 1984;23(3):295-301.
1984: Fahn S; Bressman S B
Should levodopa therapy for Parkinsonism be started early or late? Evidence against early treatment.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1984;11(1 Suppl):200-5.
1984: Stern Y; Mayeux R; Ilson J; Fahn S; Cote L
Pergolide therapy for Parkinson's disease: neurobehavioral changes.
Neurology 1984;34(2):201-4.
1984: Ilson J; Fahn S; Côté L
Painful dystonic spasms in Parkinson's disease.
Advances in neurology 1984;40():395-8.
1984: Reches A; Fahn S
Catechol-O-methyltransferase and Parkinson's disease.
Advances in neurology 1984;40():171-9.
1984: Reches A; Wagner H R; Barkai A I; Jackson V; Yablonskaya-Alter E; Fahn S
Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain.
Psychopharmacology 1984;83(2):155-8.
1984: Reches A; Jackson-Lewis V; Fahn S
Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.
Psychopharmacology 1984;82(4):330-4.
1983: Burke R E; Fahn S
Chlorpromazine methiodide acts at the vestibular nuclear complex to induce barrel rotation in the rat.
Brain research 1983;288(1-2):273-81.
1983: Burke R E; Fahn S
Studies of somatostatin-induced barrel rotation in rats.
Regulatory peptides 1983;7(3):207-20.
1983: Fahn S
High dosage anticholinergic therapy in dystonia.
Neurology 1983;33(10):1255-61.
1983: Reches A; Wagner R H; Jackson V; Yablonskaya-Alter E; Fahn S
Dopamine receptors in the denervated striatum: further supersensitivity by chronic haloperidol treatment.
Brain research 1983;275(1):183-5.
1983: Reches A; Hassan M N; Jackson V R; Fahn S
Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosine.
Life sciences 1983;33(2):157-60.
1983: Reches A; Fahn S
Lithium in the "on-off" phenomenon.
Annals of neurology 1983;14(1):91-2.
1983: Reches A; Burke R E; Kuhn C M; Hassan M N; Jackson V R; Fahn S
Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
The Journal of pharmacology and experimental therapeutics 1983;225(3):515-21.
1983: Reches A; Hassan M N; Jackson V; Fahn S
Lithium interferes with reserpine-induced dopamine depletion.
Annals of neurology 1983;13(6):671-3.
1983: Jiang D; Reches A; Fahn S
Normal erythrocyte uptake of L-DOPA in Parkinson's, Huntington's, and related diseases.
Neurology 1983;33(6):793-6.
1983: Fahn S
Treatment of tardive dyskinesia: use of dopamine-depleting agents.
Clinical neuropharmacology 1983;6(2):151-8.
1983: Burke R E; Fahn S
Electroencephalographic studies of chlorpromazine methiodide and somatostatin-induced barrel rotation in rats.
Experimental neurology 1983;79(3):704-13.
1983: Reches A; Burke R E; Jiang D; Wagner H R; Fahn S
Neurotensin interacts with dopaminergic neurons in rat brain.
Peptides 1983;4(1):43-8.
1983: Ilson J; Fahn S; Mayeux R; Cote L J; Snider S R
Pergolide treatment in parkinsonism.
Advances in neurology 1983;37():85-94.
1983: Fahn S
Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents.
Advances in neurology 1983;37():267-76.
1983: Burke R E; Fahn S
Double-blind evaluation of trihexyphenidyl in dystonia.
Advances in neurology 1983;37():189-92.
1983: Lobo Antunes J; Fahn S; Cote L
Normal pressure hydrocephalus and Parkinson's disease.
Journal of neural transmission. Supplementum 1983;19():225-31.
1983: Gollomp S M; Fahn S; Burke R E; Reches A; Ilson J
Therapeutic trials in Meige syndrome.
Advances in neurology 1983;37():207-13.
1983: Fahn S
High-dosage anticholinergic therapy in dystonia.
Advances in neurology 1983;37():177-88.
1982: Fahn S
Pathophysiological mechanisms of adverse effects from levodopa therapy.
Rinsho shinkeigaku = Clinical neurology 1982;22(12):1088-91.
1982: Burke R E; Fahn S; Jankovic J; Marsden C D; Lang A E; Gollomp S; Ilson J
Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs.
Neurology 1982;32(12):1335-46.
1982: Reches A; Jiang D; Fahn S
Effect of 3',4'-dihydroxy-2-methyl-propriophenone (U-0521) on catechol-O-methyltransferase activity and on DOPA accumulation in rat red blood cells and corpus striatum.
Biochemical pharmacology 1982;31(21):3415-8.
1982: Burke R E; Fahn S; Wagner H R; Smeal M
Chlorpromazine methiodide-induced barrel rotation: an antimuscarinic effect.
Brain research 1982;250(1):133-42.
1982: Mayeux R; Fahn S
Paroxysmal dystonic choreoathetosis in a patient with familial ataxia.
Neurology 1982;32(10):1184-6.
1982: Reches A; Fahn S
3-O-methyldopa blocks dopa metabolism in rat corpus striatum.
Annals of neurology 1982;12(3):267-71.
1982: Reches A; Mielke L R; Fahn S
3-o-methyldopa inhibits rotations induced by levodopa in rats after unilateral destruction of the nigrostriatal pathway.
Neurology 1982;32(8):887-8.
1982: Reches A; Wagner H R; Jackson V; Fahn S
Chronic lithium administration has no effect on haloperidol-induced supersensitivity of pre- and postsynaptic dopamine receptors in rat brain.
Brain research 1982;246(1):172-7.
1982: Reches A; Jiang D; Fahn S
Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa.
Naunyn-Schmiedeberg's archives of pharmacology 1982;320(1):34-7.
1982: Reches A; Wagner H R; Jiang D; Jackson V; Fahn S
The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain.
Life sciences 1982;31(1):37-44.
1982: Reches A; Fahn S; Bhawan J
Chronic dopa feeding of mice.
Neurology 1982;32(6):684-5.
1982: Prasad A L; Fahn S
A semiautomated method for the rapid determination of dopa: comparison of plasma and erythrocyte-dopa concentration in levodopa-treated patients.
Biochemical medicine 1982;27(3):297-304.
1982: Burke R E; Fahn S; Jankovic J; Marsden C D; Lang A E; Gollomp S; Ilson J
Tardive dystonia and inappropriate use of neuroleptic drugs.
Lancet 1982;1(8284):1299.
1982: Matison R; Mayeux R; Rosen J; Fahn S
"Tip-of-the-tongue" phenomenon in Parkinson disease.
Neurology 1982;32(5):567-70.
1982: Fahn S
A case of post-traumatic tic syndrome.
Advances in neurology 1982;35():349-50.
1982: Fahn S
The clinical spectrum of motor tics.
Advances in neurology 1982;35():341-4.
1981: Burke R E; Fahn S; Mayeux R; Weinberg H; Louis K; Willner J H
Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.
Neurology 1981;31(8):1022-5.
1981: Floud A; Fahn S
L-DOPA (L-3,4-dihydroxyphenylalanine) uptake by human red blood cells.
Biochimica et biophysica acta 1981;645(2):165-9.
1980: Fahn S
Levodopa provocative test for Huntington's disease.
The New England journal of medicine 1980;303(15):884.
1980: Burke R E; Fahn S; Gold A P
Delayed-onset dystonia in patients with "static" encephalopathy.
Journal of neurology, neurosurgery, and psychiatry 1980;43(9):789-97.
1980: Jankovic J; Fahn S
Physiologic and pathologic tremors. Diagnosis, mechanism, and management.
Annals of internal medicine 1980;93(3):460-5.
1980: Mayeux R; Hunter S; Fahn S
More on myoclonus in Alzheimer disease.
Annals of neurology 1980;8(2):200.
1980: Fahn S; Côté L J; Barrett R E; Snider S R
Further experiences with low doses of bromocriptine in Parkinson's disease.
Advances in biochemical psychopharmacology 1980;23():255-60.
1980: Fahn S; Mayeux R
Unilateral Parkinson's disease and contralateral tardive dyskinesia: a unique case with successful therapy that may explain the pathophysiology of these two disorders.
Journal of neural transmission. Supplementum 1980;(16):179-85.
1979: Lesser R P; Fahn S; Snider S R; Cote L J; Isgreen W P; Barrett R E
Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy.
Neurology 1979;29(9 Pt 1):1253-60.
1979: Fahn S; Cote L J; Snider S R; Barrett R E; Isgreen W P
The role of bromocriptine in the treatment of parkinsonism.
Neurology 1979;29(8):1077-83.
1979: Fahn S; Comi R; Snider S R; Prasad A L
Effect of a catechol-O-methyl transferase inhibitor, U-0521, with levodopa administration.
Biochemical pharmacology 1979;28(7):1221-5.
1979: Forrest D V; Fahn S
Tardive dysphrenia and subjective akathisia.
The Journal of clinical psychiatry 1979;40(4):206.
1979: Shoulson I; Fahn S
Huntington disease: clinical care and evaluation.
Neurology 1979;29(1):1-3.
1979: Fahn S; Barbeau A; Calne D; Duvoisin R; Markham C; Paulson G
Symposium I: Therapeutic controversies in movement disorders.
Transactions of the American Neurological Association 1979;104():31-51.
1979: Sharma J N; Snider S R; Fahn S; Hiesiger E
Anoxic myoclonus in the rat.
Advances in neurology 1979;26():181-9.
1979: Tellerman K; Astrow A; Fahn S; Snider S R; Snider R S; Glassgold J M
Cerebellar control of catecholaminergic activities implications for drug therapy of movement disorders.
International journal of neurology 1979;13(1-4):135-55.
1979: Fahn S
Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen.
Advances in neurology 1979;26():49-84.
1978: Fahn S
Post-anoxic action myoclonus: improvement with valproic acid.
The New England journal of medicine 1978;299(6):313-4.
1978: Fahn S
Tardive dyskinesia may be only akathisia.
The New England journal of medicine 1978;299(4):202-3.
1978: Mayeux R; Fahn S
Strokes and ulcerative colitis.
Neurology 1978;28(6):571-4.
1978: Lesser R P; Fahn S
Dystonia: a disorder often misdiagnosed as a conversion reaction.
The American journal of psychiatry 1978;135(3):349-52.
1978: Fahn S; Calne D B
Considerations in the management of parkinsonism.
Neurology 1978;28(1):5-7.
1978: Fahn S
Treatment of tardive dyskinesia with combined reserpine and alpha-methyltyrosine.
Transactions of the American Neurological Association 1978;103():100-3.
1977: Johnson W G; Fahn S
Treatment of vascular hemiballism and hemichorea.
Neurology 1977;27(7):634-6.
1977: Hutt C S; Snider S R; Fahn S
Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
Neurology 1977;27(6):503-10.
1977: Snider S R; Miller C; Prasad A L; Jackson V; Fahn S
Is dopamine a neurohormone of the adrenal medulla? Studies with morphine stimulation.
Naunyn-Schmiedeberg's archives of pharmacology 1977;297(1):17-22.
1977: Snider S R; Sahar D; Prasad A L; Fahn S
Changes in adrenal dopamine concentration after metyrapone or ACTH administration: implications for the in vivo regulation of dopamine beta-hydroxylase by glucocorticoids.
Life sciences 1977;20(6):1077-85.
1977: Fahn S
New approaches in the management of hyperkinetic movement disorders.
Advances in experimental medicine and biology 1977;90():157-73.
1976: Snider S R; Hutt C; Stein B; Prasad A L; Fahn S
Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnover.
The Journal of pharmacy and pharmacology 1976;28(7):563-6.
1976: Snider S R; Fahn S; Isgreen W P; Cote L J
Primary sensory symptoms in parkinsonism.
Neurology 1976;26(5):423-9.
1976: Fahn S; Côté L J
Stability of enzymes in post-mortem rat brain.
Journal of neurochemistry 1976;26(5):1039-42.
1976: Isgreen W P; Chutorian A M; Fahn S
Sequential parkinsonism and chorea following "mild" inluenza.
Transactions of the American Neurological Association 1976;101():56-60.
1976: Isgreen W P; Fahn S; Barrett R E; Snider S R; Chutorian A M
Carbamazepine in torsion in dystonia.
Advances in neurology 1976;14():411-6.
1976: Fahn S; Eldridge R
Definition of dystonia and classification of the dystonic states.
Advances in neurology 1976;14():1-5.
1976: Fahn S
Biochemistry of the basal ganglia.
Advances in neurology 1976;14():59-89.
1975: Prasad A L; Fahn S; Isgreen W P
Dopamine: a sensitive automated assay and examples of levodopa therapy.
Biochemical medicine 1975;14(1):24-32.
1975: Fahn S; Snider S; Prasad A L; Lane E; Makadon H
Normalization of brain serotonin by L-tryptophan in levodopa-treated rats.
Neurology 1975;25(9):861-5.
1975: Fahn S; Isgreen W P
Long-term evaluation of amantadine and levodopa combination in parkinsonism by double-blind corssover analyses.
Neurology 1975;25(8):695-700.
1975: Snider S R; Fahn S; Cote L J; Isgreen W P
Letter: Pain, paresthesia and parkinsonism.
The New England journal of medicine 1975;293(4):200.
1974: Prockop L; Fahn S; Barbour P
Homovanillic acid: entry rate kinetics for transfer from plasma to cerebrospinal fluid.
Brain research 1974;80(3):435-42.
1974: Earnest M P; Fahn S; Karp J H; Rowland L P
Normal pressure hydrocephalus and hypertensive cerebrovascular disease.
Archives of neurology 1974;31(4):262-6.
1974: Fahn S
"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
Neurology 1974;24(5):431-41.
1974: Prasad A L; Fahn S
3-O-methyl metabolites of catecholamines: automated fluorometric assay and their plasma levels in patients receiving levodopa and carbidopa.
Biochemical medicine 1974;9(2):136-47.
1974: Cook D G; Fahn S; Brait K A
Chronic manganese intoxication.
Archives of neurology 1974;30(1):59-64.
1974: Johnson W G; Fahn S
Treatment of vascular hemichorea and hemiballismus with perphenazine.
Transactions of the American Neurological Association 1974;99():222-4.
1973: Prasad A L; Fahn S
Fluorometric determination of homovanillic acid in the presence of other acid metabolites of catecholamines.
Journal of neurochemistry 1973;21(6):1551-4.
1973: Brait K; Fahn S; Schwarz G A
Sporadic and familial parkinsonism and motor neuron disease.
Neurology 1973;23(9):990-1002.
1972: Fahn S
Differential diagnosis of tremors.
The Medical clinics of North America 1972;56(6):1363-75.
1972: Fahn S
Treatment of choreic movements with perphenazine.
Diseases of the nervous system 1972;33(10):653-8.
1972: Fahn S
L-dopa effect in Huntington's chorea.
The New England journal of medicine 1972;287(9):467-8.
1972: Fahn S; Prasad A L; Delesie R
A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brain.
Analytical biochemistry 1972;46(2):557-75.
1971: Fahn S; Libsch L R; Cutler R W
Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor.
Journal of the neurological sciences 1971;14(4):427-55.
1971: Fahn S; Craddock G; Kumin G
Acute toxic psychosis from suicidal overdosage of amantadine.
Archives of neurology 1971;25(1):45-8.
1971: DiGiacomo J N; Fahn S; Glass J B; Westlake R J
A case with Gilles de la Tourette's syndrome: recurrent refractoriness to haloperidol, and unsuccessful treatment with L-dopa.
The Journal of nervous and mental disease 1971;152(2):115-7.
1971: O'Brien C P; DiGiacomo J N; Fahn S; Schwarz G A
Mental effects of high-dosage levodopa.
Archives of general psychiatry 1971;24(1):61-4.
1970: Schwarz G A; Fahn S
Newer medical treatment in parkinsonism.
The Medical clinics of North America 1970;54(3):773-85.
1969: Fahn S; Rodman J S; Côté L J
Association of tyrosine hydroxylase with synaptic vesicles in bovine caudate nucleus.
Journal of neurochemistry 1969;16(9):1293-300.
1968: Fahn S
Correlation of sodium-potassium-activated adenosine triphosphatase with acetyl cholinesterase of the Electrophorus electric organ.
Experientia 1968;24(6):544-5.
1968: Fahn S; Côté L J
Regional distribution of sodium-potassium activated adenosine triphosphatase in the brain of the Rhesus monkey.
Journal of neurochemistry 1968;15(5):433-6.
1968: Fahn S; Koval G J; Albers R W
Sodium-potassium-activated adenosine triphosphatase of Electrophorus electric organ. V. Phosphorylation by adenosine triphosphate-32P.
The Journal of biological chemistry 1968;243(8):1993-2002.
1968: Fahn S; Cote L
Regional and subcellular distribution of tyrosine hydroxylase.
Neurology 1968;18(3):293-4.
1968: Fahn S; Côté L J
Regional distribution of gamma-aminobutyric acid (GABA) in brain of the rhesus monkey.
Journal of neurochemistry 1968;15(3):209-13.
1968: Fahn S; Côté L J
Regional distribution of choline acetylase in the brain of the rhesus monkey.
Brain research 1968;7(2):323-5.
1966: Fahn S; Hurley M R; Koval G J; Albers R W
Sodium-potassium-activated adenosine triphosphatase of Electrophorus electric organ. II. Effects of N-ethylmaleimide and other sulfhydryl reagents.
The Journal of biological chemistry 1966;241(8):1890-5.
1966: Fahn S; Koval G J; Albers R W
Sodium-potassium-activated adenosine triphosphatase of Electrophorus electric organ. I. An associated sodium-activated transphosphorylation.
The Journal of biological chemistry 1966;241(8):1882-9.
1964: FAHN S; ALBERS R W; KOVAL G J
ELECTROPHORUS ADENOSINE TRIPHOSPHATASE: SODIUM-ACTIVATED EXCHANGE AFTER N-ETHYLALEIMIDE TREATMENT.
Science (New York, N.Y.) 1964;145():283-4.
1964: ROWLAND L P; FAHN S; HIRSCHBERG E; HARTER D H
MYOGLOBINURIA.
Archives of neurology 1964;10():537-62.
1963: ROWLAND L P; FAHN S; SCHOTLAND D L
MCARDLE'S DISEASE. HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
Archives of neurology 1963;9():325-42.
1963: ALBERS R W; FAHN S; KOVAL G J
THE ROLE OF SODIUM IONS IN THE ACTIVATION OF ELECTROPHORUS ELECTRIC ORGAN ADENOSINE TRIPHOSPHATASE.
Proceedings of the National Academy of Sciences of the United States of America 1963;50():474-81.
1963: FAHN S; SCHOTLAND D L; ROWLAND L P
MCARDLE'S DISEASE: HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
Transactions of the American Neurological Association 1963;88():145-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Stanley Fahn

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Living Beings

Procedures

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Stanley Fahn (preview)

All Publications